Navigation Links
Thoratec Announces Appointment of Steven H. Collis to Board of Directors
Date:11/19/2007

the company."

Thoratec Corporation is a world leader in hemodynamic restoration therapy- developing products to treat cardiovascular disease. The company's product line includes the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com.

Some of the preceding paragraphs, contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These statements can be identified by the words, "expects," "continues," "projects," "hopes," "believes," "could," and other similar words. Actual results, events or performance could differ materially from these forward-looking statements based on a variety of factors, many of which are beyond Thoratec's control. Therefore, readers are cautioned not to put undue reliance on these statements. Investors are cautioned that all such statements involve risk and uncertainties. Forward- looking statements contained in this press release should be considered in light of these factors, and those factors discussed from time to time in Thoratec's public reports filed with the Securities and Exchange Commission, such as those discussed under the heading, "Risk Factors," in Thoratec's most recent annual report on Form 10-K and quarterly report on Form 10-Q. These forward-looking statements speak only as of the date hereof. Thoratec undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may b
'/>"/>

SOURCE Thoratec Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
2. Thoratec Presentation at Bear Stearns Conference To Be Webcast
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Lindsley F. Kimball Research Institute of the New York Blood ... Explorations winner, an initiative funded by the Bill ... , Head of the Laboratory of Molecular Parasitology will ... Innovative 3-D in vitro culturing system for ... to help eliminate onchocerciasis (river blindness) in Africa ...
(Date:5/21/2013)... The congress of the ERA-EDTA ... the biggest congress in Europe ... are in Istanbul to share ... pioneering studies have been presented: / (1) ... VIA HEMODIALYSATE REDUCES ESA USE" By SFP-iron ...
(Date:5/21/2013)... Toronto, Canada (PRWEB) May 21, 2013 ... there is a strong push within the industry ... Development and Manufacturing Organizations and pharma companies often ... time frames. , Microtablets, developed in collaboration with ... how effective outsourcing can bring products to market ...
(Date:5/21/2013)... 2013  Personal Genome Diagnostics Inc. (PGDx), today ... and expertise in genomic analysis of defined cancer ... with Blueprint Medicines.  PGDx is an innovator in ... in tumors, and Blueprint Medicines is an expert ... genetically defined patient population. "This collaboration ...
Breaking Biology Technology:New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3
... 4 Biotest Pharmaceuticals,Corporation, a leading developer ... new management team as part of the ... Pharmaceuticals (Nasdaq:,NABI) and the creation of Biotest ... Pharmaceuticals Corporation Completes Acquisition,of Nabi Biologics Business ...
... Dec. 4 Biotest Pharmaceuticals,Corporation, a leading ... it has completed the acquisition of the ... unit for $185 million,in cash. Biotest Pharmaceuticals ... announced the acquisition of the Nabi Biologics ...
... Genetics to Provide Testing for Important Cancer and Leukemia Group ... ... Genzyme Genetics,a business unit of Genzyme Corporation (Nasdaq: GENZ ), ... sponsored by,the National Cancer Institute. The multi-center study will include 1,700,newly diagnosed ...
Cached Biology Technology:Biotest Pharmaceuticals Corporation Announces Management Team 2Biotest Pharmaceuticals Corporation Announces Management Team 3Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 2Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 3National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 2National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 3National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 4
(Date:5/20/2013)... PAUL (MAY 20, 2013) University of Minnesota Medical ... Minnesota, in partnership with the University,s Brain Tumor Program, ... nerve sheath tumors (MPNST) that allow them to discover ... cancer. , The research was published this week in ... Sleeping Beauty transposon method, researchers in the lab of ...
(Date:5/20/2013)... New research suggests that a compound abundant in ... escape death. , By altering a very specific ... cells into normal cells that die as scheduled. , ... a process that would cause them to die on ... This study in cells, led by Ohio State University ...
(Date:5/20/2013)... University of Bristol and published online today in the ... how the brain and inner ear developed in dinosaurs. ... Sciences, together with Tom Hbner from the Niederschsische Landesmuseum ... year old dinosaurs. , The two palaeontologists studied different ... a very young (juvenile) individual of approximately three ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3Fossil brain teaser 2
... 2011) -- In a biotechnological tour de force, Rice ... for rapidly converting simple glucose into biofuels and petrochemical ... , Rice,s team described how it reversed one of ... beta oxidation cycle -- to engineer bacteria that produce ...
... the same songs as your neighbours may sound harmonious, ... that song-sharing amongst song sparrow populations is actually an ... "It,s been hypothesized that repertoire size and song ... quality as a mate," says lead author Janet Lapierre, ...
... 10, 2011 Do you run when you should stay? ... deficiency might be to blame, reveals new research in mice ... a paper appearing in the October 2011 issue of the ... mice lacking a certain enzyme due to genetic mutation are ...
Cached Biology News:Metabolism in reverse: Making biofuels at full-throttle pace 2Bird song-sharing like verbal sparring 2Scared of the wrong things: Lack of major enzyme causes poor threat-assessment in mice 2
... and M.W. Turner (1997). • This ... used in the production of high-quality ... immunoassays, the standardisation of antibodies and ... amplification systems, enzyme immunoassays for detecting ...
... MW: 34.2kDa Formulation: 10mM HEPES, pH ... dithiothreitiol with 50% glycerol Properites: For ... Certificate of Analysis for individual lots ... followed by gel filtration and Mono-S ...
MitoScreen (JC-1) Kit , 100 tests Consult technical datasheet for details....
Thermal Printer Paper for Monolight(tm) Luminometer 1 each...
Biology Products: